IL129715A0 - Substituted benzo (1,4) dioxanes as antiobesity agents - Google Patents

Substituted benzo (1,4) dioxanes as antiobesity agents

Info

Publication number
IL129715A0
IL129715A0 IL12971597A IL12971597A IL129715A0 IL 129715 A0 IL129715 A0 IL 129715A0 IL 12971597 A IL12971597 A IL 12971597A IL 12971597 A IL12971597 A IL 12971597A IL 129715 A0 IL129715 A0 IL 129715A0
Authority
IL
Israel
Prior art keywords
dioxanes
substituted benzo
antiobesity agents
antiobesity
agents
Prior art date
Application number
IL12971597A
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL129715A0 publication Critical patent/IL129715A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL12971597A 1996-12-30 1997-12-18 Substituted benzo (1,4) dioxanes as antiobesity agents IL129715A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77474996A 1996-12-30 1996-12-30
PCT/US1997/024019 WO1998029405A1 (en) 1996-12-30 1997-12-18 Substituted benzo[1,4]dioxanes as antiobesity agents

Publications (1)

Publication Number Publication Date
IL129715A0 true IL129715A0 (en) 2000-02-29

Family

ID=25102168

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12971597A IL129715A0 (en) 1996-12-30 1997-12-18 Substituted benzo (1,4) dioxanes as antiobesity agents

Country Status (10)

Country Link
EP (1) EP0948494A1 (en)
JP (1) JP2001507704A (en)
KR (1) KR20000062404A (en)
AU (1) AU5723098A (en)
BR (1) BR9714109A (en)
CA (1) CA2271885A1 (en)
HU (1) HUP0000768A2 (en)
IL (1) IL129715A0 (en)
NZ (1) NZ336235A (en)
WO (1) WO1998029405A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1020458B1 (en) 1998-07-31 2008-05-07 Nisshin Pharma Inc. Optically active 1,4-benzodioxine-2-carboxylic acid derivatives and process for producing the same
ES2291733T3 (en) * 2002-10-22 2008-03-01 Glaxo Group Limited MEDICAL ARYLETHANOLAMINE COMPOUNDS.
AR041724A1 (en) 2002-10-28 2005-05-26 Glaxo Group Ltd COMPOUNDS DERIVED FROM PHENETANOLAMINE AND ITS USE IN PHARMACEUTICAL COMPOSITIONS
AR057218A1 (en) * 2005-12-15 2007-11-21 Astra Ab OXAZOLIDINONE COMPOUNDS AND THEIR USE AS PONTENCIATORS OF THE METABOTROPIC GLUTAMATE RECEIVER

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5482971A (en) * 1993-10-01 1996-01-09 American Cyanamid Company Beta3 -adrenergic agents and their use in pharmaceutical compositions
DE69618634T2 (en) * 1995-05-12 2002-06-20 Nisshin Pharma Inc., Tokio/Tokyo 1,4-benzodioxin-DERIVATIVES

Also Published As

Publication number Publication date
CA2271885A1 (en) 1998-07-09
HUP0000768A2 (en) 2001-05-28
WO1998029405A1 (en) 1998-07-09
BR9714109A (en) 2000-03-21
KR20000062404A (en) 2000-10-25
NZ336235A (en) 2000-11-24
EP0948494A1 (en) 1999-10-13
JP2001507704A (en) 2001-06-12
AU5723098A (en) 1998-07-31

Similar Documents

Publication Publication Date Title
ZA977687B (en) Substituted 6,5-hetero-bicyclic derivatives
ZA977652B (en) Substituted 6,6-hetero-bicyclic derivatives
ZA976954B (en) Substituted pyrido- or pyrimido- containing 6,6- or 6,7-bicyclic derivatives
ZA9811599B (en) Ortho-anthranilamide derivatives as anti-coagulants.
AP9901572A0 (en) 2-(Purin-9 yl)-tetrahydrofur-n-3,4-diol derivatives
ZA978178B (en) Composition.
HK1018216A1 (en) New 19-nor-pregnene derivatives.
ZA975616B (en) Colored composition.
ZA975261B (en) Composition.
EP0758898A4 (en) Activin antagonists as novel contraceptives
PL332416A1 (en) Substituted heterocyclic compounds as anticarcinogenic agents
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
IL129715A0 (en) Substituted benzo (1,4) dioxanes as antiobesity agents
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
SG70589A1 (en) 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives
EP0814804A4 (en) Substituted benzopyrans
IL126780A0 (en) Substituted 1,3-benzodioxoles
HU9700545D0 (en) (2,3-dihydro-5-benzofuranyl)-acetonitril
SI0920429T1 (en) Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
HUP9903001A3 (en) Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
IL132162A0 (en) 2, 3-Epoxypropionamide derivatives
IL132162A (en) 2,3-epoxypropionamide derivatives